"Promising Breast Cancer Vaccine Aims to Eradicate Disease in Seven Years"

An experimental breast cancer vaccine has shown promising results in early trials, with 15 women in remission for up to five years despite being at high risk of relapse. The vaccine targets a protein associated with breast cancer formation and trains the immune system to destroy cells producing that protein. If successful, the vaccine could potentially eliminate breast cancer as a disease. The vaccine is currently being trialed on triple-negative breast cancer, but researchers hope to eventually administer it to healthy individuals to prevent any form of breast cancer. The next phase of the trial will involve women at high risk of breast cancer receiving the vaccine before prophylactic mastectomy surgery.